The Big Debate #5: How can pharmacy supervision be modernised without compromising patient safety?
Good evening everyone, welcome to our fifth Big Debate.
Pharmacy supervision has been at times defined as an emotive topic, and for good reasons. But no matter on which side of the argument pharmacy professionals stand it is agreed by all that patient safety should not be compromised.
A formal Community Pharmacy Supervision Practice Group – which includes members from the Association of Independent Multiple pharmacies (AIMp), the Company Chemists’ Association (CCA), the National Pharmacy Association (NPA), and the Pharmacists’ Defence Union (PDA) – first met on September 28 after sector bodies announced earlier this year that talks on pharmacy supervision had resumed.
Tonight, we’ll be holding a less formal debate – although please note that we expect our participants to abide by the C+D community principles – on the following question: how can pharmacy supervision be modernised without compromising patient safety?
Let us know your thoughts by commenting below. The “live” part of the debate will close at 8pm, but feel free to continue to exchange views for as long as you like.
C+D has introduced a streamlined functionality that allows users to mention each other in a comment. Simply use ‘@’ and type in the person’s name.
This debate will start at 7pm.